Dr. David A. Mclain, M.D.
Rheumatology (Rheumatology Physician)
- Medicare participating
At a glance
- Medical school
- Tulane University School of Medicine (1974)
- Years since graduation
- 52
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 473
Licensed in Alabama since 1981, according to the Alabama Board of Medical Examiners and Medical Licensure Commission. We show license dates only for the states that publish them in bulk; see which states do. For other states, check the state medical board.
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1974Medical school: Tulane University School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Rheumatology Physician primary
AL license 9639 (first issued 1981; active)
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Marshall Medical Centers Boaz, AL
- Northeast Alabama Regional Medical Center Anniston, AL
Medical groups
- Mclain Medical Associates PC (4 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 473
- Services billed
- 23,934
- Patients’ average age
- 71
| Service | Times | Patients |
|---|---|---|
| Injection, denosumab, 1 mg | 5,580 | 65 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 1,157 | 168 |
| Established patient office or other outpatient visit, 30-39 minutes | 695 | 403 |
| Aspiration and/or injection of fluid from large joint | 299 | 154 |
| Established patient office or other outpatient visit, 20-29 minutes | 290 | 201 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 102 | 71 |
| Injection of drug or substance under skin or into muscle | 68 | 20 |
| Hyaluronan or derivative, hyalgan, supartz or visco-3, for intra-articular injection, per dose | 58 | 22 |
| Aspiration and/or injection of fluid from small joint | 56 | 37 |
| Testing for presence of drug, read by direct observation | 54 | 49 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Hydroxychloroquine Sulfate Other prescribers in Birmingham, AL | 2,529 |
| Hydrocodone-Acetaminophen (hydrocodone/acetaminophen) Other prescribers in Birmingham, AL | 2,063 |
| Oxycodone-Acetaminophen (oxycodone hcl/acetaminophen) Other prescribers in Birmingham, AL | 1,014 |
| Tizanidine Hcl Other prescribers in Birmingham, AL | 952 |
| Gabapentin Other prescribers in Birmingham, AL | 894 |
| Tramadol Hcl Other prescribers in Birmingham, AL | 718 |
| Prednisone Other prescribers in Birmingham, AL | 642 |
| Leflunomide Other prescribers in Birmingham, AL | 634 |
| Alprazolam Other prescribers in Birmingham, AL | 509 |
| Methotrexate (methotrexate sodium) Other prescribers in Birmingham, AL | 497 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 21 companies reported 212 payments worth $222,386 in total to this clinician.
| AbbVie Inc. | $217,890 |
|---|---|
| Amgen Inc. | $957 |
| Novartis Pharmaceuticals Corporation | $666 |
| Mallinckrodt Hospital Products Inc. | $488 |
| GlaxoSmithKline, LLC. | $392 |
| UCB, Inc. | $312 |
| Pfizer Inc. | $276 |
| AstraZeneca Pharmaceuticals LP | $276 |
| Grant | $217,128 |
|---|---|
| Food and Beverage | $5,108 |
| Education | $150 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| AbbVie Inc. May 12, 2025 | Grant RINVOQ · IMMUNOLOGY | $82,650 |
| AbbVie Inc. Aug 21, 2025 | Grant RINVOQ · IMMUNOLOGY | $81,828 |
| AbbVie Inc. Apr 14, 2025 | Grant RINVOQ · IMMUNOLOGY | $26,550 |
| AbbVie Inc. Aug 22, 2025 | Grant RINVOQ · IMMUNOLOGY | $26,100 |
| Janssen Biotech, Inc. Jul 3, 2025 | Education TREMFYA · Immunology · in-kind | $90.00 |
| Mallinckrodt Hospital Products Inc. Aug 14, 2025 | Education ACTHAR · IMMUNOLOGY · in-kind Company’s descriptionRelevant medical textbook or clinical reprint | $59.99 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.